The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Brain Tumor Diagnosis and Therapeutics Market Research Report 2025

Global Brain Tumor Diagnosis and Therapeutics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1806611

No of Pages : 89

Ask Your Query

Synopsis

Brain tumors are treated with surgery, radiation therapy and chemotherapy. This report mainly focuses on brain tumor diagnosis and therapeutics market.

The global Brain Tumor Diagnosis and Therapeutics market was valued at US$ 2581 million in 2023 and is anticipated to reach US$ 4685.7 million by 2030, witnessing a CAGR of 9.8% during the forecast period 2024-2030.

North American market for Brain Tumor Diagnosis and Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Brain Tumor Diagnosis and Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Brain Tumor Diagnosis and Therapeutics in Surgery is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Brain Tumor Diagnosis and Therapeutics include GE Healthcare, Hitachi, Philips Healthcare, Siemens Healthineers, Toshiba Corporation, Fujifilm Corporation, Shimadzu Corporation, Merck & Co. and AstraZeneca, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Brain Tumor Diagnosis and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Tumor Diagnosis and Therapeutics.

Report Scope

The Brain Tumor Diagnosis and Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Brain Tumor Diagnosis and Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Brain Tumor Diagnosis and Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • GE Healthcare
  • Hitachi
  • Philips Healthcare
  • Siemens Healthineers
  • Toshiba Corporation
  • Fujifilm Corporation
  • Shimadzu Corporation
  • Merck & Co.
  • AstraZeneca
  • Bristol Myer Squibb
  • Novartis
  • Roche Diagnostics

Segment by Type

  • MRI
  • CT Scan
  • Tissue Sampling
  • PET-CT Scan
  • Cerebral Arteriogram
  • Lumbar Puncture
  • Molecular Testing
  • EEG

Segment by Application

  • Surgery
  • Radiation Therapy
  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain Tumor Diagnosis and Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 MRI
1.2.3 CT Scan
1.2.4 Tissue Sampling
1.2.5 PET-CT Scan
1.2.6 Cerebral Arteriogram
1.2.7 Lumbar Puncture
1.2.8 Molecular Testing
1.2.9 EEG
1.3 Market by Application
1.3.1 Global Brain Tumor Diagnosis and Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Surgery
1.3.3 Radiation Therapy
1.3.4 Chemotherapy
1.3.5 Immunotherapy
1.3.6 Targeted Therapy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Brain Tumor Diagnosis and Therapeutics Market Perspective (2019-2030)
2.2 Brain Tumor Diagnosis and Therapeutics Growth Trends by Region
2.2.1 Global Brain Tumor Diagnosis and Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Brain Tumor Diagnosis and Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Brain Tumor Diagnosis and Therapeutics Market Dynamics
2.3.1 Brain Tumor Diagnosis and Therapeutics Industry Trends
2.3.2 Brain Tumor Diagnosis and Therapeutics Market Drivers
2.3.3 Brain Tumor Diagnosis and Therapeutics Market Challenges
2.3.4 Brain Tumor Diagnosis and Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brain Tumor Diagnosis and Therapeutics Players by Revenue
3.1.1 Global Top Brain Tumor Diagnosis and Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Brain Tumor Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Brain Tumor Diagnosis and Therapeutics Revenue
3.4 Global Brain Tumor Diagnosis and Therapeutics Market Concentration Ratio
3.4.1 Global Brain Tumor Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Tumor Diagnosis and Therapeutics Revenue in 2023
3.5 Brain Tumor Diagnosis and Therapeutics Key Players Head office and Area Served
3.6 Key Players Brain Tumor Diagnosis and Therapeutics Product Solution and Service
3.7 Date of Enter into Brain Tumor Diagnosis and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Tumor Diagnosis and Therapeutics Breakdown Data by Type
4.1 Global Brain Tumor Diagnosis and Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Type (2025-2030)
5 Brain Tumor Diagnosis and Therapeutics Breakdown Data by Application
5.1 Global Brain Tumor Diagnosis and Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Brain Tumor Diagnosis and Therapeutics Market Size (2019-2030)
6.2 North America Brain Tumor Diagnosis and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2019-2024)
6.4 North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Brain Tumor Diagnosis and Therapeutics Market Size (2019-2030)
7.2 Europe Brain Tumor Diagnosis and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2019-2024)
7.4 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Brain Tumor Diagnosis and Therapeutics Market Size (2019-2030)
9.2 Latin America Brain Tumor Diagnosis and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Detail
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Brain Tumor Diagnosis and Therapeutics Introduction
11.1.4 GE Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.1.5 GE Healthcare Recent Development
11.2 Hitachi
11.2.1 Hitachi Company Detail
11.2.2 Hitachi Business Overview
11.2.3 Hitachi Brain Tumor Diagnosis and Therapeutics Introduction
11.2.4 Hitachi Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.2.5 Hitachi Recent Development
11.3 Philips Healthcare
11.3.1 Philips Healthcare Company Detail
11.3.2 Philips Healthcare Business Overview
11.3.3 Philips Healthcare Brain Tumor Diagnosis and Therapeutics Introduction
11.3.4 Philips Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.3.5 Philips Healthcare Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Detail
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Introduction
11.4.4 Siemens Healthineers Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.4.5 Siemens Healthineers Recent Development
11.5 Toshiba Corporation
11.5.1 Toshiba Corporation Company Detail
11.5.2 Toshiba Corporation Business Overview
11.5.3 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Introduction
11.5.4 Toshiba Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.5.5 Toshiba Corporation Recent Development
11.6 Fujifilm Corporation
11.6.1 Fujifilm Corporation Company Detail
11.6.2 Fujifilm Corporation Business Overview
11.6.3 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Introduction
11.6.4 Fujifilm Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.6.5 Fujifilm Corporation Recent Development
11.7 Shimadzu Corporation
11.7.1 Shimadzu Corporation Company Detail
11.7.2 Shimadzu Corporation Business Overview
11.7.3 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Introduction
11.7.4 Shimadzu Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.7.5 Shimadzu Corporation Recent Development
11.8 Merck & Co.
11.8.1 Merck & Co. Company Detail
11.8.2 Merck & Co. Business Overview
11.8.3 Merck & Co. Brain Tumor Diagnosis and Therapeutics Introduction
11.8.4 Merck & Co. Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.8.5 Merck & Co. Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Detail
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Brain Tumor Diagnosis and Therapeutics Introduction
11.9.4 AstraZeneca Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.9.5 AstraZeneca Recent Development
11.10 Bristol Myer Squibb
11.10.1 Bristol Myer Squibb Company Detail
11.10.2 Bristol Myer Squibb Business Overview
11.10.3 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Introduction
11.10.4 Bristol Myer Squibb Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.10.5 Bristol Myer Squibb Recent Development
11.11 Novartis
11.11.1 Novartis Company Detail
11.11.2 Novartis Business Overview
11.11.3 Novartis Brain Tumor Diagnosis and Therapeutics Introduction
11.11.4 Novartis Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.11.5 Novartis Recent Development
11.12 Roche Diagnostics
11.12.1 Roche Diagnostics Company Detail
11.12.2 Roche Diagnostics Business Overview
11.12.3 Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Introduction
11.12.4 Roche Diagnostics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.12.5 Roche Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock